Article
[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].
Nihon rinsho. Japanese journal of clinical medicine - 1 Jul 1994
Iwabuchi S, Osada T, Takatori M, Yoshida H
Abstract excerpt
Possible effects of IFN and SNMC combination therapy for active liver cirrhosis were described. 28 patients with active liver cirrhosis were treated with natural IFN alpha 3-6 MU TIW for 3-17 months (mean, 8 +/- 6). 8 of 28 patients received combination therapy of SNMC (40 ml iv, TIW). 8 (29%) of 28 patients sustained normal ALT levels with no relapse (complete response) which involved 6 patients with persistent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.